Gilead Sciences: About to start trials of an inhaled version of Remdesivir
Gilead Sciences CEO in a statement announced on Monday that the company is about to start trials of an inhaled version of its experimental coronavirus
Gilead Sciences CEO in a statement announced on Monday that the company is about to start trials of an inhaled version of its experimental coronavirus
Leave a Comment